Molecular diagnosis and treatment of drug-resistant hepatitis B virus

doi:10.3748/wjg.v20.i19.5708

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 19

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7310)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

491

WORD

216

HTML

4689

Figures (1-3)

215

Tables (1-1)

181

Sum=5792

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

880

Download

638

Sum=1518

May 21, 2014 (publication date) through Nov 13, 2024

Times Cited of This Article

Times Cited (36)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. May 21, 2014; 20(19): 5708-5720
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5708

Full Size Figure Download Figure

Figure 1 Approved anti-hepatitis B virus drugs and their resistant mutations. IC₅₀ values are dependent on the duration of drug exposure to cells, the cells used, and the protocol used.

Citation: Kim JH, Park YK, Park ES, Kim KH. Molecular diagnosis and treatment of drug-resistant hepatitis B virus. World J Gastroenterol 2014; 20(19): 5708-5720
URL: https://www.wjgnet.com/1007-9327/full/v20/i19/5708.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i19.5708